1/1
Safety of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data
Version 2 2020-08-07, 16:32
Version 1 2020-08-05, 13:58
figure
posted on 2020-08-07, 16:32 authored by Joseph A. Lasky, Gerard J. Criner, Howard M. Lazarus, Veronika Kohlbrenner, Shaun Bender, Luca RicheldiArticle full text
The above summary slide and graphical plain language summary represent the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
